AVAILABLE THERAPIES AND CURRENT MANAGEMENT OF FIBROMYALGIA: FOCUSING ON PHARMACOLOGICAL AGENTS
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, C. | - |
dc.contributor.author | Lee, S-J. | - |
dc.contributor.author | Lee, S-Y. | - |
dc.contributor.author | Seo, H-J. | - |
dc.contributor.author | Wang, S-M. | - |
dc.contributor.author | Park, M-H. | - |
dc.contributor.author | Patkar, A. A. | - |
dc.contributor.author | Koh, J. | - |
dc.contributor.author | Masand, P. S. | - |
dc.contributor.author | Pae, C-U. | - |
dc.date.accessioned | 2021-09-07T10:59:59Z | - |
dc.date.available | 2021-09-07T10:59:59Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-07 | - |
dc.identifier.issn | 1699-3993 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/112081 | - |
dc.description.abstract | Fibromyalgia (FM) is a chronic medical condition characterized by physical, psychiatric and psychological symptoms. Widespread pain, fatigue, sleep disturbances, heightened sensitivity, morning stiffness, decreased volition, depressed mood and a history of early abuse are frequently reported by patients with FM. Treatment of fibromyalgia is multidisciplinary, with an emphasis on active patient participation, medications, cognitive-behavioral therapy and physical modalities. No single medication has yet been found to sufficiently control all the symptoms of FM; currently available medication classes include antidepressants, nonsteroidal anti-inflammatory drugs, opioids, sedatives, muscle relaxants, analgesics, hypnotic agents and anticonvulsants. Hence, treatment for patients with FM, including pharmacological and non-pharmacological approaches, should be individualized based on each patient's clinical history, target symptoms and functional impairments. Although nonpharmacological modalities are also frequently used, recent research has focused on identifying more effective pharmacological treatments, particularly antidepressants and anticonvulsants. Furthermore, several new pharmacological agents have been now officially approved for the treatment of patients with FM. Thus, the purpose of this review is to help healthcare professionals make informed decisions about the appropriate use of a number of pharmacological treatments for patients with FM. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PROUS SCIENCE, SAU-THOMSON REUTERS | - |
dc.subject | PLACEBO-CONTROLLED TRIAL | - |
dc.subject | MAJOR DEPRESSIVE DISORDER | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | CLINICAL-TRIAL | - |
dc.subject | POOLED ANALYSIS | - |
dc.subject | DIABETIC POLYNEUROPATHY | - |
dc.subject | S-ADENOSYLMETHIONINE | - |
dc.subject | COMPARATIVE EFFICACY | - |
dc.subject | MULTICENTER TRIAL | - |
dc.subject | PAIN THRESHOLD | - |
dc.title | AVAILABLE THERAPIES AND CURRENT MANAGEMENT OF FIBROMYALGIA: FOCUSING ON PHARMACOLOGICAL AGENTS | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, C. | - |
dc.identifier.doi | 10.1358/dot.2011.47.7.1603503 | - |
dc.identifier.scopusid | 2-s2.0-80052727655 | - |
dc.identifier.wosid | 000294655100004 | - |
dc.identifier.bibliographicCitation | DRUGS OF TODAY, v.47, no.7, pp.539 - 557 | - |
dc.relation.isPartOf | DRUGS OF TODAY | - |
dc.citation.title | DRUGS OF TODAY | - |
dc.citation.volume | 47 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 539 | - |
dc.citation.endPage | 557 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | PLACEBO-CONTROLLED TRIAL | - |
dc.subject.keywordPlus | MAJOR DEPRESSIVE DISORDER | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | CLINICAL-TRIAL | - |
dc.subject.keywordPlus | POOLED ANALYSIS | - |
dc.subject.keywordPlus | DIABETIC POLYNEUROPATHY | - |
dc.subject.keywordPlus | S-ADENOSYLMETHIONINE | - |
dc.subject.keywordPlus | COMPARATIVE EFFICACY | - |
dc.subject.keywordPlus | MULTICENTER TRIAL | - |
dc.subject.keywordPlus | PAIN THRESHOLD | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.